Mortality causes in cancer patients with type 2 diabetes mellitus

European Journal of Cancer Prevention

Volumn 21, Issue 3, 2012, Pages 300-306

  Liu, Xiangdong ^a   Ji, Jianguang ^a   Sundquist, Kristina ^a   Sundquist, Jan ^a,b   Hemminki, Kari ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

cancer; death causes; type 2 diabetes mellitus

Indexed keywords

AGED; ARTERY DISEASE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; URINARY TRACT DISEASE;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; HUMANS; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; SWEDEN;

EID: 84859426255     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834c9cd9     Document Type: Review

References (32)

1. Adeghate E, Schattner P, Dunn E (2006). An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci 1084:1-29. (Pubitemid 47091962)
2. Brunnstrom HR, Englund EM (2009). Cause of death in patients with dementia disorders. Eur J Neurol 16:488-492.
3. Cohen J, Bilsen J, Addington-Hall J, Lofmark R, Miccinesi G, Kaasa S, et al. (2008). Population-based study of dying in hospital in six European countries. Palliat Med 22:702-710.
4. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004). Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160-1167. (Pubitemid 38747263)
5. De Marco R, Locatelli F, Zoppini G, Verlato G, Bonora E, Muggeo M (1999). Cause-specific mortality in type 2 diabetes. The Verona Diabetes study. Diabetes Care 22:756-761. (Pubitemid 29220775)
6. Eddy D, Schlessinger L, Kahn R, Peskin B, Schiebinger R (2009). Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care 32:361-366.
7. Fahmi A, Morimura S, Guo H C, Shigematsu T, Kida K, Uemura Y (2004). Production of angiotensin I converting enzyme inhibitory peptides from sea bream scales. Process Biochem 39:1195-1200. (Pubitemid 38700218)
8. Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC (2005). Cardiotoxicity of cancer therapy. J Clin Oncol 23:7685-7696. (Pubitemid 46291833)
9. Giovannucci E (2007). The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132:2208-2225. (Pubitemid 46693749)
10. Hemminki K, Li X, Sundquist K, Sundquist J (2007). Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden. Clin Exp Allergy 37:1320-1325. (Pubitemid 47372283)
11. Hemminki K, Li X, Sundquist K, Sundquist J (2008). Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalizations in Sweden. J Epidemiol Community Health 62:398-401. (Pubitemid 351579912)
12. Hemminki K, Li X, Sundquist J, Sundquist K (2010a). Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15:548-555.
13. Hemminki K, Li X, Sundquist K, Sundquist J (2010b). Familial risks for type 2 diabetes in Sweden. Diabetes Care 33:293-297.
14. Hjartaker ALH, Weiderpass E (2008). Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 630:72-93.
15. Johansson LA, Björkenstam C, Westerling R (2009). Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1094 deaths in Sweden. J Clin Epidemiol 62: 1202-1209.
16. Johansson LA, Westerling R (2000). Comparing Swedish hospital discharge records with death certificates, implications for mortality statistics. Int J Epidemiol 29:495-502. (Pubitemid 30447254)
17. Laakso M (2008). Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture. Diabetes Care 33: 442-449.
18. Miettinen H, Lehto S, Salomaa V, Mähönen M, NiemeläM, Haffner SM, et al. (1998). Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA myocardial infarction register study group. Diabetes Care 21:69-75. (Pubitemid 28030388)
19. Mossin H, Landmark BT (2010). Being present in hospital when the patient is dying - a grounded theory study of spouses, experiences. Eur J Oncol Nurs [Epub ahead of print].
20. Namjoshi S, Caccetta R, Benson HA (2008). Skin peptides: biological activity and therapeutic opportunities. J Pharm Sci 97:2524-2542.
21. Norgaard ML, Andersen SS, Schramm TK, Folke F, Jorgensen CH, Hansen ML, et al. (2010). Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction - a nationwide study. Diabetologia 53:1612-1619.
22. Orphanos GS, Ioannidis GN, Ardavanis AG (2009). Cardiotoxicity induced by tyrosine kinase inhibitors. Acta Oncol 48:964-970.
23. Redelings MD, Sorvillo F, Simon P (2006). A comparison of underlying cause and multiple causes of death: US vital statistics, 2000-2001. Epidemiology 17:100-103.
24. Ringborg ALP, Martinell M, Yin DD, Schon S, Stalhammar J (2008). Prevalence and incidence of type 2 diabetes and its complications 1996-2003 -estimates from a Swedish population-based study. Diabet Med 25:1178-1186.
25. Romero-Aroca P, Mendez-Marin I, Baget-Bernaldiz M, Fernéndez- Ballart J, Santos-Blanco E (2010). Review of the relationship between renal and retinal microangiopathy in diabetes mellitus patients. Curr Diab Rev 6: 88-101.
26. Rousseau MCPM, Pollak MN, Siemiatycki J (2006). Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 118:2105-2109.
27. Smith U, Gale EA (2009). Does diabetes therapy influence the risk of cancer? Diabetologia 52: 1699-1708.
28. Socialstyrelsen [Swedish National Board of Health and Welfare] 2005. Var dör de äldre-pasjukhus, särskilt boende eller hemma? -En registerstudie. [Where do elderly people die - in a hospital, care home, or home? - A registry study].
29. Brämer GR (1988). International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q 41:32-36.
30. Xue F, Michels KB (2007). Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86:s823-s835.
31. Zhu CF, Li GZ, Peng HB, Zhang F, Chen Y, Li Y (2010). Effect of marine collagen peptides on makers of metabolic nuclear receptors in type 2 diabetic pantients with/without hypertension. Biomed Environ Sci 23:113-120.
32. Zimmet P (2003). The burden of type 2 diabetes: are we doing enough? Diabetes Metab 29:6S9-6S18. (Pubitemid 37187086)